Have a personal or library account? Click to login
Acute hemolytic transfusion reaction caused by anti-Coa Cover

Acute hemolytic transfusion reaction caused by anti-Coa

Paid access
|Oct 2020

Abstract

Coa is a high-frequency blood group antigen in the Colton blood group system expressed on red blood cells (RBCs) of approximately 99.8 percent of random persons. Anti-Coa has been reported to cause delayed hemolytic transfusion reactions, hemolytic disease of the newborn, and accelerated clearance of RBCs in vivo. Acute hemolytic transfusion reactions (AHTRs) have not previously been reported. A 58-year-old man was hospitalized for vascular surgery. Initial blood bank evaluation revealed anti-Fya. The patient received six units of RBCs during his initial hospitalization and developed anti-E. A subsequent sample was sent to the reference laboratory when all units of RBCs appeared incompatible. Additional studies, including alloadsorptions, revealed the presence of anti-E, anti-Fya, and an apparent warm autoantibody. One unit of least-incompatible RBCs was transfused during surgery. The patient had an increase in temperature. Hemoglobinuria and a decrease in hematocrit were also noted. Due to the clinical impression of an AHTR, the pre- and postreaction samples were reevaluated in the reference laboratory and demonstrated the presence of anti-Coa in both. Based on clinical and laboratory evaluation this patient appears to have had an AHTR due to anti-Coa. This is the first known reported case of an AHTR caused by anti-Coa. Immunohematology 2001;17:45–49.

DOI: https://doi.org/10.21307/immunohematology-2019-543 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 45 - 49
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 R.B. Covin, K.S. Evans, R. Olshock, H.W. Thompson, published by American National Red Cross
This work is licensed under the Creative Commons License.